Key statistics
As of last trade Evolus Inc (EOLS:NMQ) traded at 16.82, -4.97% below its 52-week high of 17.70, set on Sep 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 16.57 |
---|---|
High | 16.97 |
Low | 16.38 |
Bid | 16.83 |
Offer | 16.85 |
Previous close | 16.44 |
Average volume | 731.35k |
---|---|
Shares outstanding | 63.09m |
Free float | 49.55m |
P/E (TTM) | -- |
Market cap | 1.04bn USD |
EPS (TTM) | -0.9073 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 15:06 BST.
More ▼
- Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Evolus Reports Second Quarter 2024 Results and Raises Full Year Revenue Guidance
- Evolus to Hold Investor Day on September 12, 2024
- Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in Australia
- Evolus to Participate in the Canaccord Genuity 44th Annual Growth Conference
- Evolus to Report Second Quarter Financial Results on July 31, 2024
- Evolus Announces Appointment of Albert G. White III to Board of Directors
- Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse™ Dermal Filler Products
More ▼